Clarius Group’s Rubius Therapeutics RUBY Stock Holding History
Bought
Maintained
Sold
Clarius Group's RUBY Position: Q2 2023 in Review
Clarius Group sold out of Rubius Therapeutics (RUBY) in Q2 2023, closing a stake of 21,393 shares — an estimated $456 sold.
Clarius Group first reported a position in RUBY in Q2 2022 and held it in 4 quarters. The position peaked at $19K in Q2 2022. 0 funds tracked by Wall St. Rank hold RUBY as of Q2 2023.
- Clarius Group reported no remaining Rubius Therapeutics position as of Q2 2023 after selling out during the quarter.
- Clarius Group sold 21,393 Rubius Therapeutics shares in Q2 2023, an estimated $456.
- Clarius Group first reported a position in Rubius Therapeutics in Q2 2022 and held it in 4 quarters.
- Clarius Group's Rubius Therapeutics position peaked at $19K in Q2 2022.
- 0 funds tracked by Wall St. Rank held Rubius Therapeutics as of Q2 2023.
Based on Clarius Group's 13F filing for Q2 2023, filed 10 Aug 2023.